<DOC>
	<DOC>NCT00092703</DOC>
	<brief_summary>The purpose of this study is to compare the gastrointestinal tolerability of an investigational drug to an approved drug in the treatment of osteoarthritis during one year treatment period.</brief_summary>
	<brief_title>Investigational Drug Versus an Approved Drug in Patients With Osteoarthritis (0663-061)(COMPLETED)</brief_title>
	<detailed_description>The duration of treatment is 12 months.</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Etoricoxib</mesh_term>
	<criteria>Osteoarthritis of the knee, hip, hand or spine which requires the use of medications for pain relief Known allergies to the study drugs</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Arcoxia</keyword>
</DOC>